Parsec Financial Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Parsec Financial Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	$1.68M	Sell	22,077 -1,172	-5%	-$97.2K	0.07%	140
2022 Q4	$1.93M	Sell	23,249 -76	-0.3%	-$6.15K	0.09%	137
2022 Q3	$1.85M	Sell	23,325 -1,800	-7%	-$152K	0.09%	134
2022 Q2	$1.87M	Sell	25,125 -11	-0%	-$826	0.09%	134
2022 Q1	$2.26M	Sell	25,136 -1,427	-5%	-$132K	0.1%	128
2021 Q4	$2.97M	Sell	26,563 -26	-0.1%	-$3.14K	0.12%	111
2021 Q3	$3.42M	Sell	26,589 -390	-1%	-$50.2K	0.15%	97
2021 Q2	$3.65M	Hold	26,979	–	–	0.17%	91
2021 Q1	$3.66M	Sell	26,979 -1,688	-6%	-$253K	0.19%	90
2020 Q4	$4.04M	Sell	28,667 -2,998	-9%	-$384K	0.22%	80
2020 Q3	$3.53M	Sell	31,665 -91	-0.3%	-$10.2K	0.22%	80
2020 Q2	$3.56M	Buy	31,756 +160	+0.5%	+$15.8K	0.23%	84
2020 Q1	$2.45M	Sell	31,596 -330	-1%	-$29.2K	0.18%	101
2019 Q4	$3.04M	Sell	31,926 -210	-0.7%	-$18.2K	0.18%	97
2019 Q3	$2.45M	Sell	32,136 -181	-0.6%	-$15K	0.15%	107
2019 Q2	$2.83M	Sell	32,317 -225	-0.7%	-$19.2K	0.18%	102
2019 Q1	$2.95M	Sell	32,542 -301	-0.9%	-$25.6K	0.19%	101
2018 Q4	$2.36M	Sell	32,843 -79	-0.2%	-$6.37K	0.17%	101
2018 Q3	$3.16M	Hold	32,922	–	–	0.2%	100
2018 Q2	$3.13M	Hold	32,922	–	–	0.21%	100
2018 Q1	$2.89M	Hold	32,922	–	–	0.2%	101
2017 Q4	$2.79M	Hold	32,922	–	–	0.19%	108
2017 Q3	$2.85M	Hold	32,922	–	–	0.21%	105
2017 Q2	$2.54M	Hold	32,922	–	–	0.2%	103
2017 Q1	$2.28M	Hold	32,922	–	–	0.19%	107
2016 Q4	$1.95M	Sell	32,922 -408	-1%	-$25.2K	0.17%	111
2016 Q3	$2.21M	Hold	33,330	–	–	0.2%	107
2016 Q2	$1.8M	Sell	33,330 -445	-1%	-$24.4K	0.17%	108
2016 Q1	$1.75M	Sell	33,775 -495	-1%	-$25.7K	0.17%	108
2015 Q4	$2.41M	Sell	34,270 -1,130	-3%	-$77.1K	0.25%	98
2015 Q3	$2.2M	Sell	35,400 -25,422	-42%	-$2M	0.24%	97
2015 Q2	$5.11M	Sell	60,822 -2,205	-3%	-$171K	0.51%	68
2015 Q1	$4.74M	Sell	63,027 -1,200	-2%	-$83.8K	0.48%	72
2014 Q4	$3.99M	Sell	64,227 -1,935	-3%	-$110K	0.42%	73
2014 Q3	$3.44M	Sell	66,162 -3,210	-5%	-$164K	0.38%	74
2014 Q2	$3.56M	Sell	69,372 -510	-0.7%	-$23K	0.39%	73
2014 Q1	$3.32M	Buy	69,882 +1,950	+3%	+$99.8K	0.38%	77
2013 Q4	$2.95M	Buy	67,932 +1,815	+3%	+$75.1K	0.35%	77
2013 Q3	$2.85M	Sell	66,117 -195	-0.3%	-$7.9K	0.37%	74
2013 Q2	$2.31M	Buy	+66,312	New	+$2.33M	0.31%	77

Other funds holding XBI

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Parsec Financial Management's XBI Position: Q1 2023 in Review

Parsec Financial Management reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 5% in Q1 2023, selling an estimated $97.2K and leaving 22,077 shares worth $1.68M. The position accounts for 0.07% of the portfolio, ranked #140.

Parsec Financial Management first reported a position in XBI in Q2 2013 and has held it in 40 quarters since. The position peaked at $5.11M in Q2 2015. 713 funds tracked by Wall St. Rank hold XBI as of Q1 2023.

Parsec Financial Management held 22,077 shares of State Street SPDR S&P Biotech ETF worth $1.68M as of Q1 2023.
Parsec Financial Management sold 1,172 State Street SPDR S&P Biotech ETF shares in Q1 2023, an estimated $97.2K.
State Street SPDR S&P Biotech ETF made up 0.07% of Parsec Financial Management's portfolio in Q1 2023, its #140 holding.
Parsec Financial Management first reported a position in State Street SPDR S&P Biotech ETF in Q2 2013 and has held it in 40 quarters since.
Parsec Financial Management's State Street SPDR S&P Biotech ETF position peaked at $5.11M in Q2 2015.
713 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2023.

Based on Parsec Financial Management's 13F filing for Q1 2023, filed 6 Apr 2023.